|
Volumn 54 Suppl 2, Issue , 2013, Pages 60-62
|
EEG abnormalities as a biomarker for cognitive comorbidities in pharmacoresistant epilepsy.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICONVULSIVE AGENT;
BIOLOGICAL MARKER;
ACTION POTENTIAL;
ANIMAL;
COGNITIVE DEFECT;
COMORBIDITY;
DRUG RESISTANCE;
ELECTROENCEPHALOGRAPHY;
EPILEPSY;
HUMAN;
METHODOLOGY;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
REVIEW;
ACTION POTENTIALS;
ANIMALS;
ANTICONVULSANTS;
BIOLOGICAL MARKERS;
COGNITION DISORDERS;
COMORBIDITY;
DRUG RESISTANCE;
ELECTROENCEPHALOGRAPHY;
EPILEPSY;
HUMANS;
MLCS;
MLOWN;
|
EID: 84880490146
PISSN: None
EISSN: 15281167
Source Type: None
DOI: 10.1111/epi.12186 Document Type: Review |
Times cited : (36)
|
References (0)
|